Skip navigation
Speakers

Moving Beyond Theory — Strategic and Tactical Decisions for Long-Term Success

January 23-24, 2018
  • Alexandria, VA

Omar Ali
Lecturer, Value Based Pricing and Outcomes Based Innovative Contracting University of Portsmouth

Sheila Arquette, Executive Director
National Association of Specialty Pharmacy (NASP);
Strategic Pharmacy Projects Advisor, Independent Health

Michelle Bridenbaker
Director, Global Medical Information, Biosimilars
Biogen

Molly Burich
Associate Director Public Policy
Boehringer Ingelheim

Ronald Dudek
President
Living Pharma, Inc.

Edric Engert
Managing Director
Abraxeolus Consulting

Thomas Felix, M.D.
Medical Director, R&D Policy, Intercontinental Region
Amgen

Joseph P. Fuhr Jr.
Lecturer, College of Population Health
Thomas Jefferson University

TJ Garrigan
Senior Director, Policy
Association for Accessible Medicines

Honorable Lora Green
Lead Administrative Patent Judge
U.S. Patent and Trademark Office

John Greenway
Principal
Trinity Partners LCC

Honorable Faith S. Hochberg
U.S. District Attorney
District of New Jersey

Tom Keonig
Executive Director, Market Access, Biosimilars
Boehringer Ingelheim Pharmaceutical Inc.

Lawrence A. (Larry) La Motte
Vice President, Public Policy
Immune Deficiency Foundation and Representative
Patients for Biologics Safety and Access (PBSA)

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Tiffany McCaslin
Senior Policy Analyst, Public Policy
National Business Group on Health

Dominic Robinson
Global Market Access, Specialty Franchise Partner
GSK

Nicholas Simmons-Stern
Senior Consultant
Trinity Partners, LLC

Eric R. Sjogren, MS, MBA, RPh
Director, Strategic Business Intelligence
Merck

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

Omar Ali
Lecturer, Value Based Pricing and Outcomes Based Innovative Contracting University of Portsmouth

Sheila Arquette, Executive Director
National Association of Specialty Pharmacy (NASP);
Strategic Pharmacy Projects Advisor, Independent Health

Michelle Bridenbaker
Director, Global Medical Information, Biosimilars
Biogen

Molly Burich
Associate Director Public Policy
Boehringer Ingelheim

Ronald Dudek
President
Living Pharma, Inc.

Edric Engert
Managing Director
Abraxeolus Consulting

Thomas Felix, M.D.
Medical Director, R&D Policy, Intercontinental Region
Amgen

Joseph P. Fuhr Jr.
Lecturer, College of Population Health
Thomas Jefferson University

TJ Garrigan
Senior Director, Policy
Association for Accessible Medicines

Honorable Lora Green
Lead Administrative Patent Judge
U.S. Patent and Trademark Office

John Greenway
Principal
Trinity Partners LCC

Honorable Faith S. Hochberg
U.S. District Attorney
District of New Jersey

Tom Keonig
Executive Director, Market Access, Biosimilars
Boehringer Ingelheim Pharmaceutical Inc.

Lawrence A. (Larry) La Motte
Vice President, Public Policy
Immune Deficiency Foundation and Representative
Patients for Biologics Safety and Access (PBSA)

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Tiffany McCaslin
Senior Policy Analyst, Public Policy
National Business Group on Health

Dominic Robinson
Global Market Access, Specialty Franchise Partner
GSK

Nicholas Simmons-Stern
Senior Consultant
Trinity Partners, LLC

Eric R. Sjogren, MS, MBA, RPh
Director, Strategic Business Intelligence
Merck

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect